- Alphabet Inc. purchased a new stake of 2,812,500 shares in Sana Biotechnology, Inc. valued at approximately $9,816,000 during the 2nd quarter.
- Institutional investors currently own 88.23% of the company's stock, alongside adjustments from other major investment firms.
- Sana Biotechnology reported quarterly earnings of ($0.13) per share, beating consensus estimates while maintaining a market capitalization of $1.10 billion.